<DOC>
	<DOCNO>NCT02825953</DOCNO>
	<brief_summary>The present study design evaluate , premature baby RDS breathe spontaneously , efficacy combine treatment nasal continuous positive airway pressure ( CPAP ) aerosolize surfactant . The first objective investigator assess safety surfactant nebulization clinical situation , ﬁnd whether treatment aerosolize surfactant would reduce need mechanical ventilation . And aim suggest aerosolize date compare date INSURE ( intubation-surfactant-extubation ) minimally invasive surfactant therapy ( MIST ) method .</brief_summary>
	<brief_title>Does The Surfactant Administration Aerosolization Effective ?</brief_title>
	<detailed_description>Does The Surfactant Administration Aerosolization Respiratory Distress Syndrome effective Spontaneously Breathing Premature Infants ? Endotracheal bolus application natural surfactant show effective treatment idiopathic respiratory distress syndrome ( RDS ) , especially premature neonate week pregnancy &gt; 27 week . However , patient intubate nasotracheal orotracheal form treatment . This intubation carry potential risk injury dental lamina , larynx , trachea , bronchopulmonary infection , fluctuation cerebral blood flow , intra- periventricular haemorrhage ( 1 ) . In addition , many baby RDS initially respond surfactant therapy later develop chronic lung disease ( CLD ) ( 2 ) . With mind , investigator attempt administer surfactant gentle way , i.e . nebulization . Administration aerosol spontaneous respiration less traumatic avoids intubation accompany mechanical infectious risk pathophysiological effect . The present study design evaluate , premature baby RDS breathe spontaneously , efficacy combine treatment nasal continuous positive airway pressure ( CPAP ) aerosolize surfactant . The first objective investigator assess safety surfactant nebulization clinical situation , ﬁnd whether treatment aerosolize surfactant would reduce need mechanical ventilation . And aim suggest aerosolize date compare date INSURE ( intubation-surfactant-extubation ) minimally invasive surfactant therapy ( MIST ) method . Seventy-five newborn baby neonatal intensive care unit ( NICU ) Yuzuncu Yil University Medical Scholl ( Van , Turkey ) randomize treatment nebulized surfactant ( Curosurf® , Chiesi Pharmaceutics , Parma , Italy ) two control group receive INSURE MIST method . The study conduct 75 infant , 25 group . Randomization central perform use seal envelope keep neonatal ward Yuzuncu Yil University Medical Centre Hospital . Informed consent obtain parent randomization . Inclusion criterion correct gestational age &gt; 26 week &lt; 34 week , age 2-36 h , clinically radiologically diagnosed progressive RDS , FiO2 need maintain SaO2 85-95 % ; &gt; 0.4 , evident lung cardiovascular malformation . The surfactant aerosol generate ultrasonic nebulizer ( Aeroneb Pro ; Aerogen , Inc. , Sunnyvale , CA ) administer via nasal continuous positive airway pressure ( NCPAP ) equipment Laryngeal Mask Airway ( LMA ) . Surfactant dilute 40 mg/ml saline nebulization . These modification introduce enhance delivery nebulized material lung ( 3 ) . In control group , baby support type NCPAP equipment , give surfactant via endotracheal bolus application MIST method . Parameters document three different time , namely application surfactant ( 200 mg/kg BW ) , 2 h , 6 h completion nebulization application others . The infant stabilise NCPAP ( Neopuff ; Fisher Paykel , Auckland , New Zealand ) delivery room transport NICU . NCPAP NIPPV start within 30 min birth immediately randomisation . Both NCPAP NIPPV deliver neonatal ventilator ( Engström Carestation ; GE Healthcare , Madison , USA ) via short , binasal Cannula ( RAM Cannula ; Neotech , Valencia , CA ) . NCPAP pressure set 5-6 cm H2O , NIPPV set non-synchronised mode 20-30 bpm , positive end-expiratory pressure 5-6 cm H2O peak inspiratory pressure 15-20 cm H2O . FiO2 titrate 0.21-0.50 maintain oxygen saturation level 90 % -95 % , measure via pulse oximeter . Under non-invasive ventilation , surfactant administer rescue therapy infant require ≥0.40 FiO2 maintain target saturation level 90 % -95 % . Findings chest radiogram inclusion head ultrasound image take soon possible accord clinical situation evaluate grade accord criterion define Papile et al . ( 4 ) Kero et al . ( 5 ) CLD define need supplemental oxygen 36 wk gestational age . Statistical evaluation Data analyze use 20 Windows Version Statistical Package Social Sciences ( SPSS ) Program ( Chicago , IL , USA ) . Data compare use unpaired t-test Chi-square test , p-values &lt; 0.05 consider statistically significant . Ethical approval The study approve regional ethic committee Yuzuncu Yil University Institute , Van , Turkey . The regional ethic committee No : 05.05.2015/09</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Newborn</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Adult</mesh_term>
	<mesh_term>Pulmonary Surfactants</mesh_term>
	<criteria>Corrected gestational age &gt; 26 week &lt; 34 week , Age 236 h Clinically radiologically diagnose progressive RDS , FiO2 need maintain SaO2 8595 % ; &gt; 0.4 No evident lung cardiovascular malformation . Corrected gestational age &lt; 26 week &gt; 34 week , Age &gt; 36 h Premature baby RDS breathe spontaneously Evident lung cardiovascular malformation .</criteria>
	<gender>All</gender>
	<minimum_age>26 Weeks</minimum_age>
	<maximum_age>34 Weeks</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>